Company Search:
Advanced Search
Sponsored Links
Acceleron Pharma Inc Company Snapshot
Acceleron Pharma Inc operates in the Biological products exc. diagnostic sector. In addition to historical fundamental analyses, the complete report available to purchase compares Acceleron Pharma Inc with three other companies in this sector in the United States: Sangamo Therapeutics Inc (2016 sales of $19.39 million of which 100% was Research & Colloboration), Agenus Incorporation ($22.57 million of which 100% was Pharmacl preparations), and Biocryst Pharmaceuticals Inc ($26.35 million of which 100% was Pharmaceuticals).

Sales Analysis. Acceleron Pharma Inc reported sales of $27.77 million for the year ending December of 2016. This represents an increase of 53.5% versus 2015, when the company's sales were $18.10 million.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Acceleron Pharma Inc
  Stock Performance Chart for Acceleron Pharma Inc
  Stock Data: Recent Stock Performance:
  Current Price (1/19/2018): 43.04
(Figures in U.S. Dollars)
1 Week -4.6%   13 Weeks 2.0%  
4 Weeks 17.7%   52 Weeks 76.4%  
Acceleron Pharma Inc Key Data:
  Ticker: XLRN Country: United States
  Exchanges: NAS Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Biological Products Exc. Diagnostic
  2016 Sales 27,771,000
(Year Ending Jan 2017).
Employees: 121
  Currency: U.S. Dollars Market Cap: 1,911,608,430
  Fiscal Yr Ends: December Shares Outstanding: 44,414,694
  Share Type: Common Closely Held Shares: 6,639,273
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.